Detalles de la búsqueda
1.
Natural killer cells efficiently target multiple myeloma clonogenic tumor cells.
Cancer Immunol Immunother
; 70(10): 2911-2924, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33693963
2.
Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse.
Haematologica
; 106(9): 2325-2333, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32732356
3.
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Haematologica
; 106(12): 3079-3089, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179471
4.
Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity.
Br J Haematol
; 189(4): 672-683, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068246
5.
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Br J Haematol
; 188(5): 605-622, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31621063
6.
Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms.
Haematologica
; 104(5): 937-946, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30545926
7.
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia.
Haematologica
; 104(2): 288-296, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30093399
8.
Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report.
J Oncol Pharm Pract
; 25(4): 998-1002, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29690814
9.
Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis.
Blood
; 127(24): 3035-9, 2016 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27069257
10.
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Br J Cancer
; 117(2): 256-265, 2017 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28557976
11.
Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality.
Blood
; 126(7): 858-62, 2015 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26089396
12.
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.
Br J Haematol
; 161(5): 667-676, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23560534
13.
Impact of IPSS-M implementation in real-life clinical practice.
Front Oncol
; 13: 1199023, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37274292
14.
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT.
Leukemia
; 37(3): 659-669, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36596983
15.
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma.
Cancers (Basel)
; 15(2)2023 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36672481
16.
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1188818, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37342332
17.
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1243241, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37662957
18.
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1349296, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38268917
19.
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Leukemia
; 37(2): 339-347, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36566271
20.
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study.
Cancers (Basel)
; 14(23)2022 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36497281